XORTX THERAPEUTICS INC's ticker is and the CUSIP is 98420Q207. A total of 8 filers reported holding XORTX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 551 | +355.4% | 0.00% | – |
| Q2 2023 | $0 | – | 121 | +37.5% | 0.00% | – |
| Q1 2023 | $0 | – | 88 | -80.0% | 0.00% | – |
| Q4 2022 | $0 | – | 440 | +471.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 77 | -91.6% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 915 | -46.0% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 1,694 | +206.9% | 0.00% | – |
| Q4 2021 | $1,000 | – | 552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 915 | $1,000 | 0.00% |
| UBS Group AG | 5,701 | $8,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CIBC WORLD MARKET INC. | 27,000 | $36,000 | 0.00% |